title: Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.
authors.forename: James R
authors.initials: JR
authors.lastname: Anderson
authors.forename: Frederic G
authors.initials: FG
authors.lastname: Barr
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Hawkins
authors.forename: David M
authors.initials: DM
authors.lastname: Parham
authors.forename: Stephen X
authors.initials: SX
authors.lastname: Skapek
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Triche
mesh_terms: D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D018572:Disease-Free Survival; D006801:Humans; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D051761:Paired Box Transcription Factors / Q000235:genetics*; D018232:Rhabdomyosarcoma, Alveolar / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D018233:Rhabdomyosarcoma, Embryonal / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D015514:Oncogene Proteins, Fusion; C471563:PAX3-FOXO1A fusion protein, human; D051761:Paired Box Transcription Factors